Your browser doesn't support javascript.
loading
Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design.
Reitman, M L; Chu, X; Cai, X; Yabut, J; Venkatasubramanian, R; Zajic, S; Stone, J A; Ding, Y; Witter, R; Gibson, C; Roupe, K; Evers, R; Wagner, J A; Stoch, A.
Affiliation
  • Reitman ML; Clinical Pharmacology, Merck Research Laboratories, Rahway, New Jersey, USA. marc.reitman@merck.com
Clin Pharmacol Ther ; 89(2): 234-42, 2011 Feb.
Article in En | MEDLINE | ID: mdl-21191377
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Rifampin / Midazolam / Digoxin Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Rifampin / Midazolam / Digoxin Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States